Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
The pharmacological profile of ELIC, a prokaryotic GABA-gated receptor.
Thompson AJ
,
Alqazzaz M
,
Ulens C
,
Lummis SC
.
???displayArticle.abstract???
The Erwinia ligand-gated ion channel (ELIC) is a bacterial homologue of vertebrate Cys-loop ligand-gated ion channels. It is activated by GABA, and this property, combined with its structural similarity to GABA(A) and other Cys-loop receptors, makes it potentially an excellent model to probe their structure and function. Here we characterise the pharmacological profile of ELIC, examining the effects of compounds that could activate or inhibit the receptor. We confirm that a range of amino acids and classic GABA(A) receptor agonists do not elicit responses in ELIC, and we show the receptor can be at least partially activated by 5-aminovaleric acid and γ-hydroxybutyric acid, which are weak agonists. A range of GABA(A) receptor non-competitive antagonists inhibit GABA-elicited ELIC responses including α-endosulfan (IC₅₀ = 17 μM), dieldrin (IC₅₀ = 66 μM), and picrotoxinin (IC₅₀ = 96 μM) which were the most potent. Docking suggested possible interactions at the 2' and 6' pore-lining residues, and mutagenesis of these residues supports this hypothesis for α-endosulfan. A selection of compounds that act at Cys-loop and other receptors also showed some efficacy at blocking ELIC responses, but most were of low potency (IC₅₀ > 100 μM). Overall our data show that a number of compounds can inhibit ELIC, but it has limited pharmacological similarity to GLIC and to Cys-loop receptors.
Fig. 1. An alignment of channel-lining residues for a range of eukaryotic Cys-loop receptors and prokaryotic homologues. As is common for these receptors, a prime notation is used to facilitate comparison between different subunits, with 0Ⲡbeing the conserved charged residue at the start of M2. Grey indicates residue conservation. Accession numbers are: ELIC P0C7B7, GLIC Q7NDN8, 5-HT3P46098, nACh α1 P02708, Gly P23415, GABAA α1 P14867, GABAA β2 P47870, GABAA γ2 P18507, GluCl Q94900.
Fig. 2. GABA and 5-AV agonist concentrationâresponse curves (A) and example responses (B). The black bar is the application of agonist. Data = mean ± SEM, n â¥Â 4.
Fig. 3. ELIC antagonists. (A) Example traces showing inhibition by picrotoxinin (PXN). Concentrationâinhibition curves for PXN (B), α-endosulfan (C), and rimantadine (D). Inhibition was measured at the GABA EC50 (1.6 mM). Data = mean ± SEM, n â¥Â 4. Values derived from the curves can be found in Table 2.
Fig. 4. (A) An overlay of all 10 docked poses for α-endosulfan. The channel volume occupied by 10 poses are calculated from the Van der Waals radii and are shown in wireframe. Inset Structure of α-endosulfan. Scale = 2.5 à . (B) A single pose showing the channel from the side. There are hydrogen bond interactions with 6â² Thr residues from adjacent subunits. (C) The same pose is seen from above, looking down towards the cell intererior. (D) Concentration response curves show Q2â²N and T6'S mutations caused a decrease in α-endosulfan potency.
Fig. 5. Comparison of pIC50 values from ELIC with those previously reported at GLIC (Alqazzaz et al., 2011). Compounds are almost all less potent at ELIC and fewer compounds inhibit responses.
Alqazzaz,
Cys-loop receptor channel blockers also block GLIC.
2011, Pubmed
Alqazzaz,
Cys-loop receptor channel blockers also block GLIC.
2011,
Pubmed
Bocquet,
X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation.
2009,
Pubmed
Brejc,
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.
2001,
Pubmed
Buisson,
Open-channel blockers at the human alpha4beta2 neuronal nicotinic acetylcholine receptor.
1998,
Pubmed
Carland,
Characterization of the effects of charged residues in the intracellular loop on ion permeation in alpha1 glycine receptor channels.
2009,
Pubmed
Chen,
Structural model for gamma-aminobutyric acid receptor noncompetitive antagonist binding: widely diverse structures fit the same site.
2006,
Pubmed
Chiara,
[(3)H]chlorpromazine photolabeling of the torpedo nicotinic acetylcholine receptor identifies two state-dependent binding sites in the ion channel.
2009,
Pubmed
Cole,
Drosophila GABA-gated chloride channel: modified [3H]EBOB binding site associated with Ala-->Ser or Gly mutants of Rdl subunit.
1995,
Pubmed
Deeb,
Dynamic modification of a mutant cytoplasmic cysteine residue modulates the conductance of the human 5-HT3A receptor.
2007,
Pubmed
Giraudat,
The noncompetitive blocker [(3)H]chlorpromazine labels segment M2 but not segment M1 of the nicotinic acetylcholine receptor alpha-subunit.
1989,
Pubmed
Giraudat,
Structure of the high-affinity binding site for noncompetitive blockers of the acetylcholine receptor: [3H]chlorpromazine labels homologous residues in the beta and delta chains.
1987,
Pubmed
Hales,
Common determinants of single channel conductance within the large cytoplasmic loop of 5-hydroxytryptamine type 3 and alpha4beta2 nicotinic acetylcholine receptors.
2006,
Pubmed
Hibbs,
Principles of activation and permeation in an anion-selective Cys-loop receptor.
2011,
Pubmed
Hilf,
Structural basis of open channel block in a prokaryotic pentameric ligand-gated ion channel.
2010,
Pubmed
,
Xenbase
Hilf,
Structure of a potentially open state of a proton-activated pentameric ligand-gated ion channel.
2009,
Pubmed
Hilf,
X-ray structure of a prokaryotic pentameric ligand-gated ion channel.
2008,
Pubmed
Huang,
Bilobalide, a sesquiterpene trilactone from Ginkgo biloba, is an antagonist at recombinant alpha1beta2gamma2L GABA(A) receptors.
2003,
Pubmed
,
Xenbase
Ikeda,
Fipronil modulation of GABAA receptor single-channel currents.
2004,
Pubmed
Islam,
Mechanism of action of the insecticides, lindane and fipronil, on glycine receptor chloride channels.
2012,
Pubmed
Li,
The insecticide fipronil and its metabolite fipronil sulphone inhibit the rat alpha1beta2gamma2L GABA(A) receptor.
2008,
Pubmed
Liman,
Subunit stoichiometry of a mammalian K+ channel determined by construction of multimeric cDNAs.
1992,
Pubmed
,
Xenbase
Matsubayashi,
Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons.
1997,
Pubmed
McGonigle,
Molecular characterization of agonists that bind to an insect GABA receptor.
2010,
Pubmed
,
Xenbase
Parikh,
Structure of the M2 transmembrane segment of GLIC, a prokaryotic Cys loop receptor homologue from Gloeobacter violaceus, probed by substituted cysteine accessibility.
2011,
Pubmed
Ratra,
Role of human GABA(A) receptor beta3 subunit in insecticide toxicity.
2001,
Pubmed
Revah,
The noncompetitive blocker [3H]chlorpromazine labels three amino acids of the acetylcholine receptor gamma subunit: implications for the alpha-helical organization of regions MII and for the structure of the ion channel.
1990,
Pubmed
Singh,
Antidepressant binding site in a bacterial homologue of neurotransmitter transporters.
2007,
Pubmed
Spitzmaul,
The local anaesthetics proadifen and adiphenine inhibit nicotinic receptors by different molecular mechanisms.
2009,
Pubmed
Stouffer,
Structural basis for the function and inhibition of an influenza virus proton channel.
2008,
Pubmed
Tasneem,
Identification of the prokaryotic ligand-gated ion channels and their implications for the mechanisms and origins of animal Cys-loop ion channels.
2005,
Pubmed
Thompson,
Binding sites for bilobalide, diltiazem, ginkgolide, and picrotoxinin at the 5-HT3 receptor.
2011,
Pubmed
,
Xenbase
Unwin,
Refined structure of the nicotinic acetylcholine receptor at 4A resolution.
2005,
Pubmed
White,
Quorum quenching in Agrobacterium tumefaciens: chance or necessity?
2009,
Pubmed
Zhou,
LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake.
2007,
Pubmed
Zimmermann,
Ligand activation of the prokaryotic pentameric ligand-gated ion channel ELIC.
2011,
Pubmed